ProCE Banner Activity

Neoadjuvant Immune Checkpoint Blockade for Muscle-Invasive Bladder Cancer

Slideset Download
In this downloadable slideset, Matthew Galsky, MD, reviews the most recent data and ongoing clinical trials assessing the efficacy of immune checkpoint inhibitor-based therapy for patients with muscle-invasive bladder cancer.

Released: November 07, 2019

Expiration: November 05, 2020

No longer available for credit.

Share

Faculty

Matthew Galsky

Matthew Galsky, MD

Professor of Medicine
Director of Genitourinary Medical Oncology
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech TEXT Only

Faculty Disclosure

Primary Author

Matthew Galsky, MD

Professor of Medicine
Director of Genitourinary Medical Oncology
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York